glp 1 drugs medicaid Covers GLP-1 Meds for Obesity in Just 13 States As demand for weight-loss drugs
Description
[PubMed] [Google Scholar] 7.Obesity: identification, assessment and management Clinical guideline
In 2014, the FDA approved the first of these drugs specifically for weight loss for people with a BMI of 30 and above or a BMI of at least 27 with one weight-related comorbid disease, which affects more than half the U.S
Cortes, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
95% CI 1.01 to 0.07
